» Articles » PMID: 19340900

Endoscopic Ultrasound Elastography for Evaluation of Lymph Nodes and Pancreatic Masses: a Multicenter Study

Abstract

Aim: To evaluate the ability of endoscopic ultrasound (EUS) elastography to distinguish benign from malignant pancreatic masses and lymph nodes.

Methods: A multicenter study was conducted and included 222 patients who underwent EUS examination with assessment of a pancreatic mass (n = 121) or lymph node (n = 101). The classification as benign or malignant, based on the real time elastography pattern, was compared with the classification based on the B-mode EUS images and with the final diagnosis obtained by EUS-guided fine needle aspiration (EUS-FNA) and/or by surgical pathology. An interobserver study was performed.

Results: The sensitivity and specificity of EUS elastography to differentiate benign from malignant pancreatic lesions are 92.3% and 80.0%, respectively, compared to 92.3% and 68.9%, respectively, for the conventional B-mode images. The sensitivity and specificity of EUS elastography to differentiate benign from malignant lymph nodes was 91.8% and 82.5%, respectively, compared to 78.6% and 50.0%, respectively, for the B-mode images. The kappa coefficient was 0.785 for the pancreatic masses and 0.657 for the lymph nodes.

Conclusion: EUS elastography is superior compared to conventional B-mode imaging and appears to be able to distinguish benign from malignant pancreatic masses and lymph nodes with a high sensitivity, specificity and accuracy. It might be reserved as a second line examination to help characterise pancreatic masses after negative EUS-FNA and might increase the yield of EUS-FNA for lymph nodes.

Citing Articles

Usefulness of endoscopic ultrasonography for differentiating between non-functional pancreatic neuroendocrine neoplasm and intrapancreatic accessory spleen.

Kano Y, Ishikawa T, Yamao K, Mizutani Y, Iida T, Uetsuki K Sci Rep. 2025; 15(1):6385.

PMID: 39984616 PMC: 11845663. DOI: 10.1038/s41598-025-91272-w.


Ultrasound elastography: a brief clinical history of an evolving technique.

Dietrich C, Dong Y, Cui X, Fink M, Jenssen C, Moeller K Ultrasound Int Open. 2024; 10:a23786926.

PMID: 39403543 PMC: 11472523. DOI: 10.1055/a-2378-6926.


Role of contrast-enhanced harmonic endoscopic ultrasonography (EUS) and EUS elastography in pancreatic lesions.

Yamashita Y, Kitano M Clin Endosc. 2024; 57(2):164-174.

PMID: 38229442 PMC: 10984748. DOI: 10.5946/ce.2023.074.


Contrast-enhanced endoscopic ultrasound for swollen lymph nodes.

Chantarojanasiri T, Ratanachu-Ek T, Ohno E, Hirooka Y J Med Ultrason (2001). 2023; .

PMID: 37542669 DOI: 10.1007/s10396-023-01347-2.


The Latest Advancements in Diagnostic Role of Endosonography of Pancreatic Lesions.

Rogowska J, Durko L, Malecka-Wojciesko E J Clin Med. 2023; 12(14).

PMID: 37510744 PMC: 10380545. DOI: 10.3390/jcm12144630.


References
1.
Eloubeidi M, Jhala D, Chhieng D, Chen V, Eltoum I, Vickers S . Yield of endoscopic ultrasound-guided fine-needle aspiration biopsy in patients with suspected pancreatic carcinoma. Cancer. 2003; 99(5):285-92. DOI: 10.1002/cncr.11643. View

2.
Frey H . [Realtime elastography. A new ultrasound procedure for the reconstruction of tissue elasticity]. Radiologe. 2003; 43(10):850-5. DOI: 10.1007/s00117-003-0943-2. View

3.
Ardengh J, Lopes C, de Lima L, de Oliveira J, Venco F, Santo G . Diagnosis of pancreatic tumors by endoscopic ultrasound-guided fine-needle aspiration. World J Gastroenterol. 2007; 13(22):3112-6. PMC: 4172620. DOI: 10.3748/wjg.v13.i22.3112. View

4.
Tamerisa R, Irisawa A, Bhutani M . Endoscopic ultrasound in the diagnosis, staging, and management of gastrointestinal and adjacent malignancies. Med Clin North Am. 2004; 89(1):139-58, viii. DOI: 10.1016/j.mcna.2004.08.010. View

5.
Giovannini M, Hookey L, Bories E, Pesenti C, Monges G, Delpero J . Endoscopic ultrasound elastography: the first step towards virtual biopsy? Preliminary results in 49 patients. Endoscopy. 2006; 38(4):344-8. DOI: 10.1055/s-2006-925158. View